10 Updates

Subcutaneous ICD: A Lesson in FDA Approval

Source: Dr. Wes, Nov 27 2012, 6:44am CST

This morning, a nice article in the Boston Globe appeared on Boston Scientific's subcutaneous implantable cardiac defibrillator (S-ICD) that recently received FDA approval. It was a fairly balanced article, one that touched ever-so-briefly ...

Continue reading on: Dr. Wes

 
 
Update
10

1 hour ago

Biogen Idec seeking approval from the FDA for an injectable multiple sclerosis drug

Source: Boston.com  |   May 21 2013, 12:08pm CDT

The drug, called Plegridy, is a new version of the Weston biotechnology company’s first -- and hugely successful -- MS treatment, Avonex. While both drugs have the same active ingredient, interferon beta, Biogen I ...

Continue reading on: Boston.com  More like this

 
Update
9

2 hours ago

Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications

Source: PRWeb  |   May 21 2013, 11:13am CDT

Children using the abutment-free implantable bone conduction hearing device from Sophono, Inc., experience audiological results comparable to the traditionally used, competitive abutment device – and with many fewer complications, acco ...

Continue reading on: PRWeb  More like this

 

Latest Movie News

 
Update
8

3 hours ago

BioMarin Pharmaceutical Inc. Presents at UBS Global Healthcare Conference, May-21-2013 09:00 AM

Source: ETF Investor  |   May 21 2013, 10:40am CDT

Good morning, everybody. Thanks for joining us. I'm Matthew Harrison, one of the Biotech analyst here at UBS. Next up, we have BioMarin and I'm pleased to have the CFO, Dan Spiegelman presenting. Thanks. Thank you, Matt. Thank you UBS ...

Continue reading on: ETF Investor  More like this

 
Update
7

4 hours ago

FDA Nod for COV's Advanced Nellcor - Analyst Blog

Source: Zacks Investment Research  |   May 21 2013, 9:27am CDT

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest. Today, you can see them free. Are you a new Zacks Member or a visitor to Zacks.com? One ...

Continue reading on: Zacks Investment Research  More like this

 
Update
6

6 hours ago

BioElectronics Presents FDA Reclassification Panel

Source: PR Newswire  |   May 21 2013, 7:34am CDT

FREDERICK, Md., May 21, 2013 /PRNewswire/ -- BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free consumer electronic devices, announced that CEO, Andrew J. Whelan is presen ...

Continue reading on: PR Newswire  More like this

 
Update
5

6 hours ago

Hologic Receives FDA Approval for a New Low-dose 3D Mammography (Breast Tomosynthesis) Solution for Breast Cancer Screening

Source: PR Newswire  |   May 21 2013, 7:23am CDT

BEDFORD, Mass., May 21, 2013 /PRNewswire/ — Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products, with an emphasis on serving ...

Continue reading on: PR Newswire  More like this

 
Update
4

7 hours ago

2013 FDA Drug Approval Calendar

Source: The Street  |   May 21 2013, 6:25am CDT

Let's not forget the importance of European drug approvals. Here are the dates for the remaining Committee for Medicinal Products for Human Use (CHMP) meetings in 2013: May 27-30; June 24-27; July 22-25; Aug. 19-22; Sept. 16 ...

Continue reading on: The Street  More like this

 
Update
3

9 hours ago

Biogen Idec seeks FDA BLA approval for PLEGRIDY to treat multiple sclerosis

Source: News-Medical.net  |   May 21 2013, 4:32am CDT

Today Biogen Idec (NASDAQ: BIIB) announced it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for approval of PLEGRIDY™ (peginterferon beta-1a), the company's pegylated subcutaneous injectable candida ...

Continue reading on: News-Medical.net  More like this

 
Update
2

9 hours ago

Biogen Idec Submits Application to FDA for Approval of PLEGRIDY™ (Peginterferon Beta-1a) in Multiple Sclerosis

Source: Street Insider  |   May 21 2013, 3:49am CDT

WESTON, Mass.--(BUSINESS WIRE)-- Today Biogen Idec (NASDAQ: BIIB) announced it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for approval of PLEGRIDY⢠(peginterferon ...

Continue reading on: Street Insider  More like this

 
Update
1

20 hours ago

Will the FDA Approve Merck's Insomnia Drug?

Source: WalletPop  |   May 20 2013, 5:37pm CDT

It's no secret that decisions from the Food and Drug Administration are incredibly hard for investors to predict. Take for instance the FDA's rejection of Novo Nordisk's insulin drugs Tresiba and Ryzodeg in Februa ...

Continue reading on: WalletPop  More like this

 
 
 
Auto Balla Sexy Balla Sport Balla TV Balla Politics Balla Movie Balla Apple Balla Business Balla Ad Balla Celebrity Balla